Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 20, 2022

Hetero Labs Ltd Iii Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has fifty-five approved drugs.

There are five tentative approvals on HETERO LABS LTD III drugs.

Summary for Hetero Labs Ltd Iii

US Patents:	0
Tradenames:	45
Ingredients:	44
NDAs:	55

Drugs and US Patents for Hetero Labs Ltd Iii

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	ESOMEPRAZOLE MAGNESIUM	esomeprazole magnesium	CAPSULE, DELAYED REL PELLETS;ORAL	211977-002	Jun 2, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hetero Labs Ltd Iii	PREGABALIN	pregabalin	CAPSULE;ORAL	206912-002	Oct 8, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hetero Labs Ltd Iii	TENOFOVIR DISOPROXIL FUMARATE	tenofovir disoproxil fumarate	TABLET;ORAL	090636-001	Jan 26, 2018	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hetero Labs Ltd Iii	ABACAVIR SULFATE	abacavir sulfate	SOLUTION;ORAL	201107-001	Sep 26, 2016	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Hetero Labs Ltd Iii	PREGABALIN	pregabalin	CAPSULE;ORAL	206912-004	Oct 8, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

McKinsey

Johnson and Johnson

Harvard Business School

Boehringer Ingelheim

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.